1364664-42-5

Basic information

• Product Name: [2-methyl-3-(2-methylphenyl)-7-(4,5,6,7-tetrbromophthalimido)]-4(3H)-quinazolinone
• CAS NO: 1364664-42-5
• Molecular Weight: 711.002
• Mol File: 1364664-42-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [2-methyl-3-(2-methylphenyl)-7-(4,5,6,7-tetrbromophthalimido)]-4(3H)-quinazolinone(CAS DataBase Reference)
• NIST Chemistry Reference: [2-methyl-3-(2-methylphenyl)-7-(4,5,6,7-tetrbromophthalimido)]-4(3H)-quinazolinone(1364664-42-5)
• EPA Substance Registry System: [2-methyl-3-(2-methylphenyl)-7-(4,5,6,7-tetrbromophthalimido)]-4(3H)-quinazolinone(1364664-42-5)

Safety Data

• Hazardous Substances Data: 1364664-42-5(Hazardous Substances Data)

Upstream product

• 619-17-0 4-Nitroanthranilic acid 
• 95-53-4 o-toluidine 
• 740-37-4 2-methyl-3-(2-methylphenyl)-7-nitro-4(3H)-quinazolinone 
• 632-79-1 Tetrabromophthalic anhydride 
• 734-44-1 2-methyl-3-(2-methylphenyl)-7-amino-4(3H)-quinazolinone 

Relevant articles and documents

Design and synthesis of novel 7-aminoquinazoline derivatives: Antitumor and anticonvulsant activities

A novel series of 7-substituted-4(3H)-quinazolinone were designed, synthesized and evaluated for their antitumor and anticonvulsant activity. Compound 7 revealed broad-spectrum antitumor effectiveness toward numerous cell lines that belong to different tumor subpanels, whereas compounds 9 and 18 possess selective activity toward leukemia cell lines. Additionally, compounds 3, 15, 16, 18, 19 and 20 showed advanced anticonvulsant activity as well as lower neurotoxicity than reference drugs. The achieved results proved that the distinctive compounds could be valuable as a model for future devise, acclimatization and investigation to construct more active analogues.